FdaApplication
NDA 203585
Identifiers
- fda_app_no: NDA203585
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA PHARMACEUTICALS INTERNATIONAL GMBH |
| application_type | NDA |
| approval_date | 2012-10-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYNRIBO | OMACETAXINE MEPESUCCINATE | 3.5MG/VIAL | POWDER;SUBCUTANEOUS |
1 product